1649 Classen Immunotherapies, Inc. v. Biogen Idec

United States Court of Appeals
for the Federal Circuit
______________________
September 12, 2011
ERRATA
______________________
2006-1634, -1649
CLASSEN IMMUNOTHERAPIES, INC.,
Plaintiff-Appellant,
v.
BIOGEN IDEC,
Defendant-Appellee,
and
GLAXOSMITHKLINE,
Defendant-Appellee,
and
MERCK & CO., INC.,
Defendant-Cross Appellant,
and
CHIRON CORPORATION, KAISER-PERMANENTE,
INC., KAISER PERMANENTE VENTURES, KAISER
PERMANENTE INTERNATIONAL, KAISER
PERMANENTE INSURANCE COMPANY, THE
PERMANENTE FEDERATION, LLC, THE
PERMANENTE COMPANY, LLC, THE PERMANENTE
FOUNDATION, THE PERMANENTE MEDICAL
GROUP, INC., KAISER FOUNDATION HOSPITALS,
KAISER FOUNDATION ADDED CHOICE HEALTH
PLAN, INC., and KAISER FOUNDATION HEALTH
PLAN INC.,
Defendants.

-- 1 of 2 --

______________________
Decided August 31, 2011
Precedential Opinion
______________________
Please make the following change:
Page 2, the following corrections
Donald R. Ware, Foley Hoag LLP, of Boston, Massachu-
setts, for defendant-appellee, Biogen IDEC. With him on
the brief were Barbara A. Fiacco and Jeremy A. Younkin.
Of counsel were Joshua M. Hiller, Wilmer Cutler
Pickering Hale and Dorr LLP, of Boston, Massachusetts,
and David A. Wilson, of Washington, DC.

-- 2 of 2 --